Updates to the Australian Pharmaceutical Benefits Scheme
22 May 2023
Update
Services Australia has published a release detailing new and amended listings of medications on the Australian Pharmaceutical Benefits Scheme (PBS), effective from 1 May 2023.
Amendments have been made to a range of medications on the PBS, including the following medications:
- Methylphenidate (Ritalin® LA) being amended to allow access for adults with a retrospective diagnosis of ADHD. This includes access to capsules containing methylphenidate hydrochloride 10 mg, 20 mg, 30 mg, 40 mg, 60mg (modified release).
- Naltrexone (Naltrexone GH®) having a reduction in authority level for the treatment of alcohol dependence.
Enquiries regarding new and amended listings can be directed to the PBS at pbs@health.gov.au.
More news & views
18 July 2024
Apply to become a Certificate supervisor
Fellows who would like to be involved in supervising and assessing Certificate participants are invi...
18 July 2024
Call for nominations: National Assessment Panel members
Find out what’s involved in being a National Assessment Panel member and how to nominate.
15 July 2024
Name change: Supporting psychiatrists with international qualifications
The OTPRC will undergo a name change to the Australia and New Zealand Psychiatrists with Internation...